T1	Intervention 0 8	Afatinib
T2	Intervention 16 28	methotrexate
T3	Intervention 448 456	Afatinib
T4	Intervention 596 604	afatinib
T5	Intervention 619 631	methotrexate
T6	Intervention 1084 1099	salvage surgery
T7	Intervention 1103 1115	radiotherapy
T8	Intervention 1316 1396	EGFR-targeted antibody therapy (but not EGFR-targeted tyrosine-kinase inhibitors
T11	Intervention 2476 2484	afatinib
T12	Intervention 2503 2515	methotrexate
T13	Intervention 2750 2762	rash or acne
T14	Intervention 2863 2872	diarrhoea
T15	Intervention 2898 2908	stomatitis
T16	Intervention 2931 2938	fatigue
T17	Intervention 2967 2978	neutropenia
T10	Intervention 1517 1529	methotrexate
T9	Intervention 1481 1489	afatinib
T18	Intervention 1790 1892	not masked to treatment allocation; independent review of tumour response was done in a blinded manner
T19	Intervention 2344 2352	afatinib
T20	Intervention 2364 2376	methotrexate
T21	Intervention 3048 3056	afatinib
T22	Intervention 3090 3102	methotrexate
T23	Intervention 3136 3144	Afatinib
